Elevated α-hydroxybutyrate dehydrogenase as an independent prognostic factor for mortality in hospitalized patients with COVID-19.

MLA

Liu, Zeming, et al. “Elevated α-Hydroxybutyrate Dehydrogenase as an Independent Prognostic Factor for Mortality in Hospitalized Patients with COVID-19.” ESC Heart Failure, vol. 8, no. 1, Feb. 2021, pp. 644–51. EBSCOhost, https://doi.org/10.1002/ehf2.13151.

APA

Liu, Z., Li, J., Li, M., Chen, S., Gao, R., Zeng, G., Chen, D., Wang, S., Li, Q., Hu, D., Zeng, W., Guo, L., & Wu, X. (2021). Elevated α-hydroxybutyrate dehydrogenase as an independent prognostic factor for mortality in hospitalized patients with COVID-19. ESC Heart Failure, 8(1), 644–651. https://doi.org/10.1002/ehf2.13151

Chicago

Liu, Zeming, Jinpeng Li, Man Li, Sichao Chen, Rongfen Gao, Guang Zeng, Danyang Chen, et al. 2021. “Elevated α-Hydroxybutyrate Dehydrogenase as an Independent Prognostic Factor for Mortality in Hospitalized Patients with COVID-19.” ESC Heart Failure 8 (1): 644–51. doi:10.1002/ehf2.13151.